Identify Savings for Tomorrow— Today!
NuQuest/Bridge Pointe (NQBP) and myMatrixx have teamed up to maximize your MSA savings potential and minimize the risk of prolonged settlement negotiations!
Our comprehensive solution identifies and optimizes opportunities to lower costs associated with both pharmacy utilization and medical treatment.
The Pre-MSA with Drug Regimen Review (PMDR) combines a medical analysis and Drug Regimen Review to provide a unique and complete clinical evaluation
of future injury-related drug and medical costs TODAY— allowing you to control utilization and costs prior to CMS submission— TOMORROW.
Why Prepare for an MSA Now?
Since MSA guidelines, issued in June, 2009, indicated that CMS would independently price future prescription drug costs in Medicare Set-Asides (MSAs)— pharmacy utilization costs have increased significantly. Rising drug costs have caused MSA settlement amounts to double or even triple— making it more and more difficult to settle claims.
To minimize the risk of prolonged settlement negotiations and expedite case closures— and mitigate costs— NuQuest/Bridge Pointe has developed a unique approach which allows our clients to gain control of injury-related drug utilization, medical treatment, and other high costs associated with a MSA— early in the process. By identifying and reducing expenses TODAY, significant savings may be realized in time for settlement— TOMORROW.
Next Page "How the Program Works"